Congress: Target the Middlemen Who Drive Up Drug Costs

David Balto authored an opinion in Healthcare Dive on why Congress should target PBMs, the middlemen, that drive up drugs costs.

United States-Mexico-Canada Agreement (USMCA)

Congress Bans Gag-Clauses on Pharmacists

Letter from David A. Balto on behalf of Consumer Action and CPPC to the Federal Trade Commission, re

The Promise of Biosimilars

FTC's Past Advocacy on PBMs is Misguided

David Balto Sends Letter to HELP Committee Regarding Need for PBM Reform

Unions and Consumer Groups Submit Comments to FTC Encouraging it to Investigate PBM Practices

Congress: Target the Middlemen Who Drive Up Drug Costs

Consumer Groups Ask FTC to Implement Rules Against Pharma Rebate Walls

FTC’s current approach to pharmaceutical merger enforcement is too lax.

Consumer Groups Submit Letter to Chairwoman Maloney Thanking Her For Her Work on AbbVie

Secretary of HHS Becerra May Play Large Role In Combatting Rebate Walls.

Consumer Groups Recommend Increased Enforcement Against Pharmaceutical Rebate Walls

Consumer Groups and Unions Submit Letter in Support of PBM Bill Lowering Drug Prices

No tags yet.

The Coalition to